Long-term Results of Stereotactic Body Radiation Therapy in Medically Inoperable Stage I Non-Small Cell Lung Cancer

Robert D Timmerman; Chen Hu; Jeff M Michalski; Jeffrey C Bradley; James Galvin; David W Johnstone; Hak Choy

doi:10.1001/jamaoncol.2018.1258

Long-term Results of Stereotactic Body Radiation Therapy in Medically Inoperable Stage I Non-Small Cell Lung Cancer

JAMA Oncol. 2018 Sep 1;4(9):1287-1288. doi: 10.1001/jamaoncol.2018.1258.

Authors

Robert D Timmerman¹, Chen Hu^{2

3}, Jeff M Michalski⁴, Jeffrey C Bradley⁴, James Galvin⁵, David W Johnstone⁶, Hak Choy¹

Affiliations

¹ Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas.
² NRG Oncology Statistics and Data Management Center, Philadelphia, Pennsylvania.
³ Sydney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland.
⁴ Department of Radiation Oncology, Washington University in St Louis, St Louis, Missouri.
⁵ Imaging and Radiation Oncology Core, Philadelphia, Pennsylvania.
⁶ Division of Cardiothoracic Surgery, Medical College of Wisconsin, Milwaukee.

Abstract

This study evaluates 5-year data from the NRG Oncology RTOG 0236 trial on the effects of sterotactic body radiation therapy in patients with inoperable stage I non–small cell lung cancer.

MeSH terms

Carcinoma, Non-Small-Cell Lung / pathology
Carcinoma, Non-Small-Cell Lung / radiotherapy*
Disease-Free Survival
Humans
Lung Neoplasms / pathology
Lung Neoplasms / radiotherapy*
Neoplasm Recurrence, Local
Neoplasm Staging
Radiosurgery / methods*
Time Factors
Treatment Outcome

Abstract

MeSH terms

Grants and funding